This topic contains a solution. Click here to go to the answer

Author Question: A 62.0-kg woman runs up a flight of stairs having a rise of 4.28 m in a time of 4.20 s. What average ... (Read 60 times)

deesands

  • Hero Member
  • *****
  • Posts: 514
A 62.0-kg woman runs up a flight of stairs having a rise of 4.28 m in a time of 4.20 s. What average power did she supply?
 a. 63.2 W
  b. 619 W
  c. 596 W
  d. 629 W
  e. 609 W

Question 2

A 180-hp engine can deliver, in SI units, an average power of ____. (1 hp = 746 W)
 a. 2.4E1 W
  b. 4.1E+3 W
  c. 1.3E+5 W
  d. 1.8E+2 W
  e. 9.3E+2 W



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

momo1250

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

b

Answer to Question 2

c




deesands

  • Member
  • Posts: 514
Reply 2 on: Jul 28, 2018
Thanks for the timely response, appreciate it


brbarasa

  • Member
  • Posts: 308
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The eye muscles are the most active muscles in the whole body. The external muscles that move the eyes are the strongest muscles in the human body for the job they have to do. They are 100 times more powerful than they need to be.

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library